Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
56
PHR Quote, Financials, Valuation and Earnings
Last price:
$25.93
Seasonality move
:
-3.54%
Day range:
$25.92 - $27.30
52-week range:
$17.07 - $30.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.47x
P/B ratio:
5.47x
Volume:
659.1K
Avg. volume:
591.3K
1-year change:
5.71%
Market cap:
$1.5B
Revenue:
$419.8M
EPS (TTM):
-$0.74
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $148.7M | $213.2M | $280.9M | $356.3M | $419.8M | |
| Revenue Growth (YoY) | 19.15% | 43.42% | 31.74% | 26.84% | 17.83% | |
| Cost of Revenues | $52.4M | $81.4M | $109.3M | $124M | $134.9M | |
| Gross Profit | $96.3M | $131.8M | $171.6M | $232.3M | $284.9M | |
| Gross Profit Margin | 64.77% | 61.83% | 61.1% | 65.2% | 67.86% | |
| R&D Expenses | $22.6M | $52.3M | $91.2M | $112.3M | $117.4M | |
| Selling, General & Admin | $83.4M | $175.1M | $231.6M | $226.9M | $197.7M | |
| Other Inc / (Exp) | $1K | -$78K | -$175K | -$1.1M | $2M | |
| Operating Expenses | $122M | $248.7M | $348.2M | $368.8M | $343M | |
| Operating Income | -$25.7M | -$116.8M | -$176.6M | -$136.5M | -$58.1M | |
| Net Interest Expenses | $1.6M | $1.1M | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$27.2M | -$118M | -$175.7M | -$135.3M | -$55.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $49K | $182K | $483K | $1.5M | $2.7M | |
| Net Income to Company | -$27.3M | -$118.2M | -$176.1M | -$136.9M | -$58.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$27.3M | -$118.2M | -$176.1M | -$136.9M | -$58.5M | |
| Basic EPS (Cont. Ops) | -$0.69 | -$2.37 | -$3.36 | -$2.51 | -$1.02 | |
| Diluted EPS (Cont. Ops) | -$0.69 | -$2.37 | -$3.36 | -$2.51 | -$1.02 | |
| Weighted Average Basic Share | $39.5M | $49.9M | $52.4M | $54.6M | $57.6M | |
| Weighted Average Diluted Share | $39.5M | $49.9M | $52.4M | $54.6M | $57.6M | |
| EBITDA | -$9.6M | -$95.5M | -$148.9M | -$104M | -$25.6M | |
| EBIT | -$25.5M | -$116.8M | -$174.3M | -$133.5M | -$53.5M | |
| Revenue (Reported) | $148.7M | $213.2M | $280.9M | $356.3M | $419.8M | |
| Operating Income (Reported) | -$25.7M | -$116.8M | -$176.6M | -$136.5M | -$58.1M | |
| Operating Income (Adjusted) | -$25.5M | -$116.8M | -$174.3M | -$133.5M | -$53.5M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $48.3M | $63.4M | $83.8M | $101.2M | $115.9M | |
| Revenue Growth (YoY) | 44.6% | 31.19% | 32.34% | 20.72% | 14.54% | |
| Cost of Revenues | $18.3M | $26.5M | $31M | $34M | $38.1M | |
| Gross Profit | $30M | $36.8M | $52.8M | $67.2M | $77.9M | |
| Gross Profit Margin | 62.19% | 58.1% | 63.03% | 66.39% | 67.17% | |
| R&D Expenses | $8.1M | $20.6M | $26.5M | $28.9M | $31.8M | |
| Selling, General & Admin | $27.7M | $60.9M | $57.3M | $51.1M | $42.5M | |
| Other Inc / (Exp) | $66K | -$31K | -$42K | -$31K | $338K | |
| Operating Expenses | $40.7M | $87.4M | $90.7M | $86.6M | $81.2M | |
| Operating Income | -$10.7M | -$50.6M | -$37.9M | -$19.4M | -$3.3M | |
| Net Interest Expenses | $238K | $383K | -- | -- | $230K | |
| EBT. Incl. Unusual Items | -$10.8M | -$51M | -$37.2M | -$19.2M | -$3.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $149K | $235K | $306K | $510K | $735K | |
| Net Income to Company | -$11M | -$51.2M | -$37.5M | -$19.7M | -$3.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$11M | -$51.2M | -$37.5M | -$19.7M | -$3.9M | |
| Basic EPS (Cont. Ops) | -$0.24 | -$0.99 | -$0.70 | -$0.35 | -$0.07 | |
| Diluted EPS (Cont. Ops) | -$0.24 | -$0.99 | -$0.70 | -$0.35 | -$0.07 | |
| Weighted Average Basic Share | $45.4M | $51.9M | $53.3M | $56.7M | $58.9M | |
| Weighted Average Diluted Share | $45.4M | $51.9M | $53.3M | $56.7M | $58.9M | |
| EBITDA | -$5.6M | -$44.7M | -$29.9M | -$12M | $4.1M | |
| EBIT | -$10.6M | -$50.6M | -$36.9M | -$18.7M | -$2.7M | |
| Revenue (Reported) | $48.3M | $63.4M | $83.8M | $101.2M | $115.9M | |
| Operating Income (Reported) | -$10.7M | -$50.6M | -$37.9M | -$19.4M | -$3.3M | |
| Operating Income (Adjusted) | -$10.6M | -$50.6M | -$36.9M | -$18.7M | -$2.7M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $163.6M | $228.3M | $301.4M | $373.7M | $434.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $59.1M | $89.7M | $113.7M | $127M | $139M | |
| Gross Profit | $104.5M | $138.6M | $187.7M | $246.6M | $295.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $25.7M | $64.8M | $97.1M | $114.8M | $120.3M | |
| Selling, General & Admin | $93M | $208.3M | $228.1M | $220.7M | $189.1M | |
| Other Inc / (Exp) | $782K | -$175K | -$186K | -$1.1M | $2.3M | |
| Operating Expenses | $135.9M | $295.4M | $351.5M | $364.6M | $337.5M | |
| Operating Income | -$31.4M | -$156.8M | -$163.9M | -$118M | -$42M | |
| Net Interest Expenses | $1.5M | $1.2M | -- | -- | $139K | |
| EBT. Incl. Unusual Items | -$32.1M | -$158.2M | -$161.9M | -$117.3M | -$39.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $87K | $268K | $554K | $1.7M | $2.9M | |
| Net Income to Company | -$32.2M | -$158.4M | -$162.4M | -$119.1M | -$42.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$32.2M | -$158.4M | -$162.4M | -$119.1M | -$42.7M | |
| Basic EPS (Cont. Ops) | -$0.76 | -$3.08 | -$3.07 | -$2.17 | -$0.74 | |
| Diluted EPS (Cont. Ops) | -$0.76 | -$3.08 | -$3.07 | -$2.17 | -$0.74 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$13.7M | -$134.6M | -$134.2M | -$86M | -$9.5M | |
| EBIT | -$31M | -$156.9M | -$160.6M | -$115.2M | -$37.5M | |
| Revenue (Reported) | $163.6M | $228.3M | $301.4M | $373.7M | $434.5M | |
| Operating Income (Reported) | -$31.4M | -$156.8M | -$163.9M | -$118M | -$42M | |
| Operating Income (Adjusted) | -$31M | -$156.9M | -$160.6M | -$115.2M | -$37.5M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $48.3M | $63.4M | $83.8M | $101.2M | $115.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $18.3M | $26.5M | $31M | $34M | $38.1M | |
| Gross Profit | $30M | $36.8M | $52.8M | $67.2M | $77.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $8.1M | $20.6M | $26.5M | $28.9M | $31.8M | |
| Selling, General & Admin | $27.7M | $60.9M | $57.3M | $51.1M | $42.5M | |
| Other Inc / (Exp) | $66K | -$31K | -$42K | -$31K | $338K | |
| Operating Expenses | $40.7M | $87.4M | $90.7M | $86.6M | $81.2M | |
| Operating Income | -$10.7M | -$50.6M | -$37.9M | -$19.4M | -$3.3M | |
| Net Interest Expenses | $238K | $383K | -- | -- | $230K | |
| EBT. Incl. Unusual Items | -$10.8M | -$51M | -$37.2M | -$19.2M | -$3.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $149K | $235K | $306K | $510K | $735K | |
| Net Income to Company | -$11M | -$51.2M | -$37.5M | -$19.7M | -$3.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$11M | -$51.2M | -$37.5M | -$19.7M | -$3.9M | |
| Basic EPS (Cont. Ops) | -$0.24 | -$0.99 | -$0.70 | -$0.35 | -$0.07 | |
| Diluted EPS (Cont. Ops) | -$0.24 | -$0.99 | -$0.70 | -$0.35 | -$0.07 | |
| Weighted Average Basic Share | $45.4M | $51.9M | $53.3M | $56.7M | $58.9M | |
| Weighted Average Diluted Share | $45.4M | $51.9M | $53.3M | $56.7M | $58.9M | |
| EBITDA | -$5.6M | -$44.7M | -$29.9M | -$12M | $4.1M | |
| EBIT | -$10.6M | -$50.6M | -$36.9M | -$18.7M | -$2.7M | |
| Revenue (Reported) | $48.3M | $63.4M | $83.8M | $101.2M | $115.9M | |
| Operating Income (Reported) | -$10.7M | -$50.6M | -$37.9M | -$19.4M | -$3.3M | |
| Operating Income (Adjusted) | -$10.6M | -$50.6M | -$36.9M | -$18.7M | -$2.7M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $218.8M | $313.8M | $176.7M | $87.5M | $84.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $28.5M | $40.7M | $51.5M | $62.9M | $70.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $8.9M | $7.4M | $10.1M | $11.3M | |
| Other Current Assets | $7.3M | $2.2M | $3.3M | $4.4M | $4.6M | |
| Total Current Assets | $272.3M | $386.3M | $262.4M | $195.7M | $203.3M | |
| Property Plant And Equipment | $29.3M | $37M | $22.2M | $17.2M | $25.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $8.3M | $33.6M | $33.7M | $75.8M | $75.8M | |
| Other Intangibles | $13.2M | $30.4M | $46.6M | $77.8M | $80.9M | |
| Other Long-Term Assets | $1.7M | $4.2M | $3.3M | $2.9M | $2.7M | |
| Total Assets | $326.7M | $494.5M | $370.1M | $370.3M | $388.4M | |
| Accounts Payable | $4.4M | $5.1M | $10.8M | $8.5M | $5.6M | |
| Accrued Expenses | $17.6M | $18M | $14.4M | $28.2M | $28.8M | |
| Current Portion Of Long-Term Debt | $4.9M | $5.8M | $246K | $1.1M | $1.2M | |
| Current Portion Of Capital Lease Obligations | $1.1M | $1.3M | $5.9M | $5.4M | $7.8M | |
| Other Current Liabilities | -- | -- | -- | $5.9M | -- | |
| Total Current Liabilities | $55M | $68.4M | $79M | $110.1M | $114M | |
| Long-Term Debt | $6.5M | $7.4M | -- | $2M | $719K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $63.4M | $77.2M | $82.2M | $118.9M | $123.6M | |
| Common Stock | $449K | $521K | $542K | $577K | $601K | |
| Other Common Equity Adj | -- | -- | -- | -- | -$51K | |
| Common Equity | $263.3M | $417.3M | $287.8M | $251.4M | $264.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $263.3M | $417.3M | $287.8M | $251.4M | $264.8M | |
| Total Liabilities and Equity | $326.7M | $494.5M | $370.1M | $370.3M | $388.4M | |
| Cash and Short Terms | $218.8M | $313.8M | $176.7M | $87.5M | $84.2M | |
| Total Debt | $11.3M | $13.2M | $246K | $3.1M | $1.9M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $450.7M | $269.2M | $149.8M | $79.5M | $90.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $29.9M | $45.8M | $49.8M | $61.1M | $71.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | $7.6M | $10.3M | $11.3M | |
| Other Current Assets | $7.9M | $10.9M | $2.4M | $4M | $4.7M | |
| Total Current Assets | $507.2M | $349.2M | $240.1M | $190.9M | $215.4M | |
| Property Plant And Equipment | $27.6M | $33.9M | $26.6M | $23M | $24.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $8.2M | $33.6M | $33.7M | $75.8M | $75.8M | |
| Other Intangibles | $13.8M | $35.2M | $49.2M | $79M | $80.8M | |
| Other Long-Term Assets | $1.4M | $4.7M | $2.6M | $2.6M | $3.1M | |
| Total Assets | $561.2M | $459.1M | $353.9M | $372.1M | $400.4M | |
| Accounts Payable | $313K | $5.9M | $7.6M | $6.7M | $3.2M | |
| Accrued Expenses | $15.1M | $15.3M | $21.6M | $29M | $27.9M | |
| Current Portion Of Long-Term Debt | $4.1M | $6.1M | -- | -- | $8.3M | |
| Current Portion Of Capital Lease Obligations | $1.2M | $1.3M | $7.7M | $8.3M | $957K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $50.7M | $70.8M | $83M | $108.3M | $110.7M | |
| Long-Term Debt | $5.5M | $6M | -- | -- | $6.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $57.9M | $77.9M | $90.2M | $119.3M | $118.2M | |
| Common Stock | $503K | $527K | $548K | $587K | $608K | |
| Other Common Equity Adj | -- | -- | -- | $1K | $384K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $503.3M | $381.2M | $263.6M | $252.7M | $282.2M | |
| Total Liabilities and Equity | $561.2M | $459.1M | $353.9M | $372.1M | $400.4M | |
| Cash and Short Terms | $450.7M | $269.2M | $149.8M | $79.5M | $90.9M | |
| Total Debt | $9.6M | $12.1M | -- | -- | $14.5M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$27.3M | -$118.2M | -$176.1M | -$136.9M | -$58.5M | |
| Depreciation & Amoritzation | $15.9M | $21.3M | $25.3M | $29.5M | $27.9M | |
| Stock-Based Compensation | $13.5M | $36.1M | $58.8M | $71.6M | $67M | |
| Change in Accounts Receivable | -$6.6M | -$10.2M | -$11.1M | -$11.2M | -$8.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.9M | -$74.7M | -$90.1M | -$32.4M | $32.4M | |
| Capital Expenditures | $18.6M | $30.8M | $26.2M | $25.1M | $24.1M | |
| Cash Acquisitions | -$6.5M | -$34.4M | -- | -$14.6M | -- | |
| Cash From Investing | -$25.1M | -$65.2M | -$26.2M | -$39.7M | -$24.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$23.3M | -$4.3M | -$5.7M | -$6.8M | -$7.8M | |
| Repurchase of Common Stock | -$5M | -$9M | -$19.4M | -$12.2M | -- | |
| Other Financing Activities | -$266K | -$4.5M | -$613K | -$2.3M | -$7.6M | |
| Cash From Financing | $150.7M | $235M | -$20.8M | -$17.1M | -$11.5M | |
| Beginning Cash (CF) | $90.3M | $218.8M | $313.8M | $176.7M | $87.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $128.5M | $95M | -$137.1M | -$89.2M | -$3.2M | |
| Ending Cash (CF) | $218.8M | $313.8M | $176.7M | $87.5M | $84.2M | |
| Levered Free Cash Flow | -$15.7M | -$105.5M | -$116.3M | -$57.5M | $8.3M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$11M | -$51.2M | -$37.5M | -$19.7M | -$3.9M | |
| Depreciation & Amoritzation | $4.9M | $5.9M | $7M | $6.7M | $6.9M | |
| Stock-Based Compensation | $5.8M | $14.2M | $17.1M | $16.8M | $17.2M | |
| Change in Accounts Receivable | -$912K | -$6.1M | -$1.5M | -$1.4M | -$1.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5.5M | -$33.6M | -$13.7M | -$721K | $14.9M | |
| Capital Expenditures | $6.9M | $7M | $6.1M | $5.4M | $7.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6.9M | -$7M | -$6.1M | -$5.4M | -$7.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.1M | -$1.5M | -$1.4M | -$1.3M | -$1.4M | |
| Repurchase of Common Stock | -$1.1M | -$4.3M | -$7M | -- | -- | |
| Other Financing Activities | -$703K | -$113K | -- | -$1.8M | -$358K | |
| Cash From Financing | $244.3M | -$4M | -$7.2M | -$1.8M | -$838K | |
| Beginning Cash (CF) | $218.8M | $313.8M | $176.7M | $87.5M | $84.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -$1K | $31K | |
| Additions / Reductions | $231.9M | -$44.6M | -$26.9M | -$8M | $6.6M | |
| Ending Cash (CF) | $450.7M | $269.2M | $149.8M | $79.5M | $90.9M | |
| Levered Free Cash Flow | -$12.4M | -$40.7M | -$19.7M | -$6.2M | $7.5M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$32.2M | -$158.4M | -$162.4M | -$119.1M | -$42.7M | |
| Depreciation & Amoritzation | $17.2M | $22.2M | $26.4M | $29.2M | $28.1M | |
| Stock-Based Compensation | $16.4M | $44.5M | $61.8M | $71.3M | $67.4M | |
| Change in Accounts Receivable | -$5.3M | -$15.4M | -$6.6M | -$11.1M | -$8.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$4.5M | -$102.9M | -$70.1M | -$19.4M | $48M | |
| Capital Expenditures | $22.4M | $30.9M | $25.3M | $24.5M | $26M | |
| Cash Acquisitions | -- | -- | -- | -$14.6M | -- | |
| Cash From Investing | -$28.9M | -$65.4M | -$25.3M | -$39M | -$26M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$23.8M | -$4.7M | -$5.7M | -$6.6M | -$7.9M | |
| Repurchase of Common Stock | -$6.1M | -$12.2M | -$22M | -$5.2M | -- | |
| Other Financing Activities | -$869K | -$3.9M | -- | -$4.1M | -$6.2M | |
| Cash From Financing | $393.8M | -$13.3M | -$24M | -$11.8M | -$10.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $360.4M | -$181.5M | -$119.4M | -$70.2M | $11.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$26.9M | -$133.8M | -$95.4M | -$43.9M | $21.9M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$11M | -$51.2M | -$37.5M | -$19.7M | -$3.9M | |
| Depreciation & Amoritzation | $4.9M | $5.9M | $7M | $6.7M | $6.9M | |
| Stock-Based Compensation | $5.8M | $14.2M | $17.1M | $16.8M | $17.2M | |
| Change in Accounts Receivable | -$912K | -$6.1M | -$1.5M | -$1.4M | -$1.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5.5M | -$33.6M | -$13.7M | -$721K | $14.9M | |
| Capital Expenditures | $6.9M | $7M | $6.1M | $5.4M | $7.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6.9M | -$7M | -$6.1M | -$5.4M | -$7.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.1M | -$1.5M | -$1.4M | -$1.3M | -$1.4M | |
| Repurchase of Common Stock | -$1.1M | -$4.3M | -$7M | -- | -- | |
| Other Financing Activities | -$703K | -$113K | -- | -$1.8M | -$358K | |
| Cash From Financing | $244.3M | -$4M | -$7.2M | -$1.8M | -$838K | |
| Beginning Cash (CF) | $218.8M | $313.8M | $176.7M | $87.5M | $84.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -$1K | $31K | |
| Additions / Reductions | $231.9M | -$44.6M | -$26.9M | -$8M | $6.6M | |
| Ending Cash (CF) | $450.7M | $269.2M | $149.8M | $79.5M | $90.9M | |
| Levered Free Cash Flow | -$12.4M | -$40.7M | -$19.7M | -$6.2M | $7.5M | |
Get PHR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PHR
Sector
P/E ratio
--
24.07x
PEG ratio
--
0.00x
P/B ratio
5.47x
1.81x
Price / LTM sales
3.47x
1.67x
Growth Metrics
PHR
Sector
Revenue growth
14.54%
4.06%
Earnings growth
--
7.49%
Revenue (5-year growth)
27.46%
8.01%
Earnings forecast
$0.16
-$0.20
Profitability
PHR
Sector
Profitability FY 2024
$284.9M
$47.5M
Return on invested capital
-16.16%
-16.26%
Return on assets
-11.25%
-13.27%
Return on equity
-16.36%
-18.61%
Earnings Date
Last Earnings Date
May
28
Next Earnings Date
Sep
4
Estimated Next Earnings Date
Aug
27
Balance Sheet
PHR
Sector
Total cash
$90.9M
$35.7M
Short term investments
--
$29.7M
Total assets
$388.4M
$106.9M
Long term debt
$14.5M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
